Corient Capital Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$918K Hold
4,485
0.07% 233
2022
Q2
$918K Sell
4,485
-365
-8% -$77.4K 0.07% 238
2022
Q1
$1.15M Buy
4,850
+831
+21% +$195K 0.08% 226
2021
Q4
$919K Buy
4,019
+665
+20% +$146K 0.06% 237
2021
Q3
$649K Sell
3,354
-344
-9% -$69.7K 0.05% 304
2021
Q2
$787K Buy
3,698
+531
+17% +$112K 0.06% 257
2021
Q1
$647K Buy
3,167
+557
+21% +$110K 0.06% 268
2020
Q4
$475K Sell
2,610
-769
-23% -$131K 0.05% 280
2020
Q3
$565K Buy
3,379
+35
+1% +$5.89K 0.06% 241
2020
Q2
$544K Sell
3,344
-975
-23% -$175K 0.07% 238
2020
Q1
$747K Sell
4,319
-182
-4% -$36.2K 0.12% 153
2019
Q4
$903K Sell
4,501
-31
-0.7% -$6.36K 0.11% 186
2019
Q3
$958K Buy
4,532
+798
+21% +$167K 0.14% 166
2019
Q2
$725K Buy
3,734
+712
+24% +$131K 0.11% 189
2019
Q1
$497K Buy
3,022
+115
+4% +$20.3K 0.08% 221
2018
Q4
$547K Buy
2,907
+1,354
+87% +$250K 0.1% 195
2018
Q3
$264K Hold
1,553
0.04% 237
2018
Q2
$255K Buy
+1,553
New +$254K 0.04% 237

Other funds holding CME

Corient Capital Partners's CME Position: Q3 2022 in Review

Corient Capital Partners held its CME Group (CME) position steady in Q3 2022 at 4,485 shares worth $918K. The position accounts for 0.07% of the portfolio, ranked #233.

Corient Capital Partners first reported a position in CME in Q2 2018 and has held it in 18 quarters since. The position peaked at $1.15M in Q1 2022. 1,145 funds tracked by Wall St. Rank hold CME as of Q3 2022.

  • Corient Capital Partners held 4,485 shares of CME Group worth $918K as of Q3 2022.
  • Corient Capital Partners left its CME Group share count unchanged in Q3 2022.
  • CME Group made up 0.07% of Corient Capital Partners's portfolio in Q3 2022, its #233 holding.
  • Corient Capital Partners first reported a position in CME Group in Q2 2018 and has held it in 18 quarters since.
  • Corient Capital Partners's CME Group position peaked at $1.15M in Q1 2022.
  • 1,145 funds tracked by Wall St. Rank held CME Group as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.